FDA announces plans to fast track development of OTC naloxone, NYC overdose deaths spike and Paris Jackson talks mental health rumors.
According to the Morbidity and Mortality Weekly Report, the number of overdose deaths involving benzodiazepines is on the rise. Over the last 20 years, bento-related overdose deaths have risen over 800%.
Does Cannabis Use Cause Schizophrenia? [New York Times]
Experts discuss the possible link between heavy use of the more potent cannabis and mental illness. Federal prohibition currently prevents the necessary research.
The famous heir took to Instagram to dispel media reports about her reportedly entering a mental health facility for care. “Yes i’ve taken a break from work and social media and my phone because it can be too much sometimes, and everyone deserves a break, but i am happy and healthy and feeling better than ever!” she wrote.
Overdose Deaths In NYC Reached Record Levels In 2017 [MarketWatch]
A new report by the New York City Department of Health and Mental Hygiene states that there were 1,487 overdose deaths in NYC in 2017 – the highest number of overdose deaths in the city since 2000.
The FDA has announced its plans to help companies develop over-the-counter naloxone. “This is the first time the FDA has proactively developed and tested a DFL [Drug Facts Label] for a drug to support development of an OTC product,” said Scott Gottlieb.
Winter Depression Is Caused By Vitamin Deficiency [South Side Times]
A look at seasonal affective disorder and the root causes that may lead to the winter blues.
New bill would penalize adults from smoking in the car with kids under 13.